DiaMedica Therapeutics Inc. Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.50M-0.02M-0.03M
Gross Profit 0.50M-0.02M-0.03M
Operating items
Research & Development 3.21M4.52M7.90M8.21M8.77M7.84M13.11M19.06M
Selling, General & Administrative 1.31M2.74M3.69M4.49M4.88M6.16M8.16M7.62M
Operating Expenses 4.52M7.26M11.59M12.70M13.65M14.00M21.27M26.68M
Operating Income -4.52M-6.76M-11.59M-12.70M-13.65M-14.00M-21.27M-26.68M
EBIT -4.52M-6.76M-11.59M-12.70M-13.65M-14.00M-21.27M-26.68M
Non-operating items
Interest & Investment Income 1.95M2.30M
Other Non Operating Income 0.01M-0.07M0.12M0.23M0.08M0.35M1.93M2.27M
Non Operating Income 0.26M1.11M0.97M0.43M0.08M0.35M1.93M2.27M
Net income details
EBT -4.26M-5.65M-10.62M-12.27M-13.56M-13.65M-19.34M-24.41M
Tax Provisions 0.08M0.03M0.03M0.03M0.03M0.04M0.03M
Profit After Tax -4.26M-5.73M-10.65M-12.29M-13.59M-13.68M-19.38M-24.44M
Income from Continuing Operations -4.26M-5.73M-10.65M-12.29M-13.59M-13.68M-19.38M-24.44M
Consolidated Net Income -4.26M-5.73M-10.65M-12.29M-13.59M-13.68M-19.38M-24.44M
Income towards Parent Company -4.26M-5.73M-10.65M-12.29M-13.59M-13.68M-19.38M-24.44M
Net Income towards Common Stockholders -4.26M-5.73M-10.65M-12.29M-13.59M-13.68M-19.38M-24.44M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 11.84M11.96M14.14M18.78M26.44M26.44M37.95M42.86M
EBITDA -4.52M-5.73M-10.65M-12.30M-13.64M-13.70M-19.30M-24.43M